drugset / Trial / NCT03291418
To Compare the Gastrointestinal Safety of a 14-Day Oral Dosing Regimen of ATB-346 to Sodium Naproxen in Healthy Subjects
RandomizedParallel-groupQuadruple-blindPrevention
Summary
A Double-Blind, Controlled Study to Compare the Gastrointestinal Safety of a 14-Day Oral Dosing Regimen of ATB-346 to Sodium Naproxen in Healthy Subjects
Timeline
- Start
- 2017-09-08
- Primary completion
- 2018-03-31
- Completion
- 2018-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ATB-346 | Small molecule | 250 mg | Oral |
| Comparator | Naproxen | Small molecule | 550 mg | Oral |